ExLibris header image
SFX Logo
Title: Oxidative killing of microorganisms by phagocytic cells
Source:

Trends in Biochemical Sciences [0968-0004] Roos, Dirk yr:1977


Collapse list of basic services Basic
Full text
Full text available via Elsevier SD Backfile Biochemistry
GO
Full text available via EZB-NALI5-00465 Elsevier Archive NL
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Vanhaesebroeck, B. "PI3K signalling: the path to discovery and understanding." Nature reviews. Molecular cell biology 13.3 (2012): 195-203. Link to SFX for this item
2. Wong, K. "Targeting the PI3K signaling pathway in cancer." Current opinion in genetics & development 20.1 (2009): 87-90. Link to SFX for this item
3. Engelman, Jeffrey A. "Targeting PI3K signalling in cancer: Opportunities, challenges and limitations." Nature Reviews. Cancer 9.8 (2009): 550-562. Link to Full Text for this item Link to SFX for this item
4. Manning, Brendan D D. "AKT/PKB signaling: Navigating downstream." Cell 129.7 (2007): 1261-74. Link to SFX for this item
5. Kahn, A. "Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance." Nature medicine 6.8 (2000): 924-8. Link to Full Text for this item Link to SFX for this item
6. Dennis, Jaclyn A. "Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations." Drug resistance updates 11.1-2 (2008): 32-50. Link to SFX for this item
7. Karnoub, AE E. "Ras oncogenes: split personalities." Nature reviews. Molecular cell biology 9.7 (2008): 517-531. Link to Full Text for this item Link to SFX for this item
8. Cheng, H. "Targeting the phosphoinositide 3-kinase pathway in cancer." Nature Reviews. Drug Discovery 8.8 (2009): 627-44. Link to Full Text for this item Link to SFX for this item
9. Der, P. J. "Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer." Oncogene 26.22 (2007): 3291-3310. Link to Full Text for this item Link to SFX for this item
10. Pagliarini, R. "Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure." EMBO reports 16.3 (2015): 280-296. Link to Full Text for this item Link to SFX for this item
11. Hennessy, Bryan T T. "Exploiting the PI3K/AKT pathway for cancer drug discovery." Nature reviews. Drug discovery 4.12: 988-1004. Link to SFX for this item
12. Yuan, T L L. "PI3K pathway alterations in cancer: variations on a theme." Oncogene 27.41 (2008): 5497-510. Link to Full Text for this item Link to SFX for this item
13. Garcia-Echeverria C, C C. "Drug discovery approaches targeting the PI3K/Akt pathway in cancer." Oncogene 27.41 (2008): 5511-5526. Link to Full Text for this item Link to SFX for this item
14. Nicholson, KM M. "The protein kinase B/Akt signalling pathway in human malignancy." Cellular signalling 14.5 (2002): 381-395. Link to Full Text for this item Link to SFX for this item
15. Taniguchi, Cullen M M. "Critical nodes in signalling pathways: insights into insulin action." Nature reviews. Molecular cell biology 7.2: 85-96. Link to SFX for this item
16. Engelman, Jeffrey A. "MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling." Science 316.5827 (2007): 1039-43. Link to SFX for this item
17. Cantley, Lewis C C. "Ras, PI(3)K and mTOR signalling controls tumour cell growth." Nature 441.7092 (2006): 424-430. Link to Full Text for this item Link to SFX for this item
18. Zhou, M. "Insulin-mediated translocation of GLUT-4-containing vesicles is preserved in denervated muscles." American journal of physiology. endocrinology and metabolism 278.6 (2000): 1019-26. Link to SFX for this item
19. Farmer, H. "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy." Nature 434.7035 (2005): 917-21. Link to Full Text for this item Link to SFX for this item
20. Morgensztern, D. "PI3K/Akt/mTOR pathway as a target for cancer therapy." Anti-cancer drugs 16.8: 797-803. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced